Skip to main content

Table 1 Active ingredients of the EMINENT model of care intervention for patients allocated to receive the EMINENT intervention

From: Implementing a nurse-enabled, integrated, shared-care model involving specialists and general practitioners in breast cancer post-treatment follow-up: a study protocol for a phase II randomised controlled trial (the EMINENT trial)

Active ingredient

Personnel involved

Specific activities

Nurse Clinic (30–60 min)

Mode: face to face or telehealth

Specialist Cancer Nursea and patient

• Treatment summary

• Survivorship care planning

• Collaborative planning for health goals

• Post-treatment education

Booster Nurse Clinicb (10–30 min)

Mode: face to face or telehealth

Specialist Cancer Nursea and patient

• Survivorship care planning

• Collaborative planning for health goals

Pharmacist Consultationc (20 min)

Mode: face to face or telehealth

Cancer Pharmacist and patient

• Medication reconciliation

• Medication education

Case conference with GP (5–30 min)

Mode: teleconference

Specialist Cancer Nursea and GP (± one more healthcare team member)

• Nurse presents treatment summary and survivorship care plan

• Follow-up responsibilities of the GP negotiated

• GP questions answered

• Additional education and support provided to other healthcare team members (e.g. Practice Nurse)

Shared follow-up care

Mode: face to face or telehealth

Cancer specialist, GP, and Specialist Cancer Nursea and patient

• Cancer specialist reviews patient, orders mammogram, and completes full physical examination every 6 months for 2 years post-diagnosis, then every 12 months up to 5 years post-diagnosis

• GP reviews patient as per survivorship care plan at least every 12 months (e.g. for general health and comorbidity management, chronic disease management planning, psychosocial screening, management of cancer treatment toxicities and cancer-related symptoms, allied health referrals)

• GP contacts nurse interventionist with any patient concerns

  1. aMedical Oncology Clinical Nurse Consultant, Breast Care Nurse, or McGrath Breast Care Nurse
  2. bOffered to patients who have delays in GP involvement greater than 3 months (up to 18 months)
  3. cOffered to patients who have completed chemotherapy and/or are scheduled to receive aromatase inhibitor, or have completed surgery and radiotherapy